arsenic trioxide has been researched along with Lupus Erythematosus, Systemic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoura, Z; Ebbo, M; Gaborit, B; Hachulla, E; Hamidou, M; Hardouin, JB; Néel, A; Poupon, J; Rieger, F; Sibilia, J; Viallard, JF; Volteau, C | 1 |
| Chen, E; Hu, H; Li, Y; Zhang, T; Zhu, X | 1 |
| Bobé, P; Chelbi-Alix, MK | 1 |
| Benihoud, K; Bobé, P; Bonardelle, D; Chelbi-Alix, MK; Opolon, P | 1 |
| Lin, SX; Xia, XR; Zhou, Y | 1 |
1 trial(s) available for arsenic trioxide and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic).
Topics: Adult; Antibodies, Monoclonal, Humanized; Arsenic Trioxide; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Severity of Illness Index; Treatment Outcome | 2021 |
4 other study(ies) available for arsenic trioxide and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Effects of Arsenic Trioxide on INF-gamma Gene Expression in MRL/lpr Mice and Human Lupus.
Topics: Adult; Animals; Arsenic Trioxide; Arsenicals; Cells, Cultured; Female; Gene Expression; Humans; Interferon-gamma; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Male; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Oxides; Spleen; Young Adult | 2018 |
[New therapeutic perspectives for arsenic: from acute promyelocytic leukemia to autoimmune diseases].
Topics: Animals; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Autoimmune Diseases; Disease Models, Animal; Growth Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Mice; Oxides | 2008 |
Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice.
Topics: Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Cytokines; Drug Evaluation, Preclinical; Enzyme Activation; fas Receptor; Glutathione; Humans; Lupus Erythematosus, Systemic; Lymphocyte Activation; Lymphoproliferative Disorders; Mice; Mice, Inbred MRL lpr; Nitric Oxide; Oxidation-Reduction; Oxides; Syndrome | 2006 |
[Effects of arsenic trioxide on the autoimmunity and survival time in BXSB lupus mice].
Topics: Animals; Antibodies, Antinuclear; Arsenic Trioxide; Arsenicals; Autoimmunity; Enzyme-Linked Immunosorbent Assay; Immunoglobulin G; Injections, Intraperitoneal; Interferon-gamma; Kidney; Lupus Erythematosus, Systemic; Mice; Oxides; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spleen; Survival Analysis | 2007 |